OncoSec Medical Incorporated

Simbol: ONCS

NASDAQ

0.2772

USD

Tržna cena danes

  • -0.0457

    Razmerje P/E

  • -0.0010

    Razmerje PEG

  • 1.65M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

OncoSec Medical Incorporated (ONCS) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za OncoSec Medical Incorporated (ONCS). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja OncoSec Medical Incorporated, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

41.1912.34620.4
25.1
27
11.4
28.7
32
37.9
5
5.1
2.5
0
0
0

balance-sheet.row.short-term-investments

0000
0
23.2
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.inventory

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

10.252.93.22.5
3.4
1.6
1.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-current-assets

51.4415.249.222.8
28.5
28.6
12.5
29.4
33.6
38.3
5.2
5.5
2.9
0
0
0

balance-sheet.row.property-plant-equipment-net

17.975.66.46.8
1
1.3
2.4
2.8
1.8
0.6
0.2
0.1
0.1
0
0
0

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

1.480.40.40
0
0
0
0
0
0.5
1.2
1.9
2.7
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

1.480.40.40
0
0
0
0
0
0.5
1.2
1.9
2.7
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

2.290.60.30.3
0.4
0.4
0.3
0.2
0.2
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

21.746.67.17.1
1.4
1.6
2.7
3
2
1.1
1.3
1.9
2.8
0
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

73.1821.956.329.9
29.9
30.2
15.2
32.4
35.6
39.4
6.5
7.4
5.7
0
0
0

balance-sheet.row.account-payables

0000
0
0
3.3
0
0
1.2
0.7
0.4
0.4
0
0
0

balance-sheet.row.short-term-debt

6.2222.11.5
0.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

14.194.15.26.4
0
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

19.244.65.98.2
4.9
5.8
0.1
3.5
2.9
0.1
1
1.6
6.2
0
0
0

balance-sheet.row.total-non-current-liabilities

34.199.110.26.4
0.6
1.5
1.1
0.9
0
1.2
0.7
1
1.5
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
-1.2
-0.7
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

16.395.26.16.4
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

59.6515.818.216
5.6
7.3
4.5
4.4
2.9
1.3
1.8
3
8
0
0
0

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0.01000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

-1158.6-286-251.8-206.6
-164.4
-134.1
-94.9
-73.5
-46.6
-25.4
-13.4
-6.2
-3.8
-0.1
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

1.480.2-0.10
0.2
0
0
-0.4
-0.3
-0.1
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

1170.65291.8289.9220.5
188.5
157
105.6
101522492
79276.8
63406.6
18.1
10.6
1.5
0
0
0

balance-sheet.row.total-stockholders-equity

13.546.138.113.9
24.3
22.9
10.7
28.1
32.7
38.1
4.7
4.4
-2.4
0
0
0

balance-sheet.row.total-liabilities-and-stockholders-equity

73.1821.956.329.9
29.9
30.2
15.2
32.4
35.6
39.4
6.5
7.4
5.7
0
0
0

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

13.546.138.113.9
24.3
22.9
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

73.18---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
23.2
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

20.416.27.37.8
0.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

-20.78-6.1-38.6-12.5
-25.1
-3.8
-11.4
-28.7
-32
-37.9
-5
-5.1
-2.5
0
0
0

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju OncoSec Medical Incorporated opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

-29.39-34.2-45.2-42.3
-30.3
-39.1
-21.4
-26.9
-21.2
-12
-7.2
-2.4
-3.8
0
0
0

cash-flows.row.depreciation-and-amortization

0.941.11.11
0.2
0.3
0.4
0.4
0.7
0.8
0.7
0.7
0.3
0
0
0

cash-flows.row.deferred-income-tax

00-0.8-0.1
0.2
0
0
0
0
0
0
0
-67.8
0
0
0

cash-flows.row.stock-based-compensation

1.281.65.13.5
3.5
8.3
4
6.1
2.6
1.8
0.5
0.3
67.8
0
0
0

cash-flows.row.change-in-working-capital

2.05-1.2-2.53.8
-3.5
2.2
-0.3
2.3
0.3
0.3
0.3
0
0.2
0
0
0

cash-flows.row.account-receivables

0000
0
0
0
0
0
0
0
0
-391.2
0
0
0

cash-flows.row.inventory

0000
0
0
0
0
0
0
0
0
38
0
0
0

cash-flows.row.account-payables

-1.38-1.4-2.63.6
-0.7
0
-0.2
0.9
1.1
0.7
0.3
0
353.2
0
0
0

cash-flows.row.other-working-capital

3.430.20.10.2
-2.8
2.2
-0.1
1.5
-0.8
-0.4
0
0
0.2
0
0
0

cash-flows.row.other-non-cash-items

0.120.60.50.9
0.8
5.2
0
0.3
0.1
0.2
0.1
-2.9
2
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

-24.99000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-0.24-0.2-0.80
0
-0.1
0
-1.6
-1.4
-0.5
-0.1
-0.1
-0.3
0
0
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
-25.5
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
23.2
2.3
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

-0.26-0.2-0.80
23.2
-23.3
0
-1.6
-1.4
-0.5
-0.1
-0.1
-0.3
0
0
0

cash-flows.row.debt-repayment

-1.15-1.3-0.6-0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0.04062.830
27.9
32.3
0
17.5
13.6
27.9
7.2
7.8
4.1
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

4.650.16-1.5
-0.6
6.6
0.1
-1.4
-0.3
14.4
-1.7
-0.8
0
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

3.54-1.268.228.4
27.2
38.9
0.1
16.1
13.3
42.4
5.5
7
4.1
0
0
0

cash-flows.row.effect-of-forex-changes-on-cash

-0.08-0.100
-0.1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-21.55-33.725.6-4.8
21.3
-7.6
-17.3
-3.3
-5.8
32.9
-0.2
2.7
2.5
0
0
0

cash-flows.row.cash-at-end-of-period

41.1912.34620.4
25.1
3.8
11.4
28.7
32
37.9
5
5.1
2.5
0
0
0

cash-flows.row.cash-at-beginning-of-period

62.744620.425.1
3.8
11.4
28.7
32
37.9
5
5.1
2.5
0
0
0
0

cash-flows.row.operating-cash-flow

-24.99-32.1-41.8-33.1
-29
-23.2
-17.3
-17.8
-17.7
-9
-5.5
-4.2
-1.3
0
0
0

cash-flows.row.capital-expenditure

-0.24-0.2-0.80
0
-0.1
0
-1.6
-1.4
-0.5
-0.1
-0.1
-0.3
0
0
0

cash-flows.row.free-cash-flow

-25.24-32.4-42.6-33.1
-29
-23.3
-17.4
-19.4
-19.1
-9.5
-5.6
-4.3
-1.6
0
0
0

Vrstica izkaza poslovnega izida

Prihodki OncoSec Medical Incorporated so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja ONCS znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

21.77---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

10.88---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0.06000.2
0.4
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

32.653748.443.4
30.4
36.1
21.4
26.9
21.2
11.9
7.1
5.5
1.7
0
0
0

income-statement-row.row.cost-and-expenses

32.653748.443.4
30.4
36.1
21.4
26.9
21.2
11.9
7.1
5.5
1.7
0
0
0

income-statement-row.row.interest-income

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

0.05000
0
6.4
0
0
0
0
0.1
-3.2
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-0.07-0.50.80.3
0.1
-3
0
0
0
0
-0.1
3.2
-2.1
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0.06000.2
0.4
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-0.07-0.50.80.3
0.1
-3
0
0
0
0
-0.1
3.2
-2.1
0
0
0

income-statement-row.row.interest-expense

0.05000
0
6.4
0
0
0
0
0.1
-3.2
0
0
0
0

income-statement-row.row.depreciation-and-amortization

0.991.11.11.2
0.7
3.7
0.4
0.4
0.7
0.8
0.7
0.7
0.3
0
0
0

income-statement-row.row.ebitda-caps

-31.66---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-32.65-37-48.4-43.4
-30.4
-36.1
-21.4
-26.9
-21.2
-11.9
-7.1
-5.5
-1.7
0
0
0

income-statement-row.row.income-before-tax

-32.72-37.5-47.6-43.1
-30.3
-39.1
-21.4
-26.9
-21.2
-12
-7.1
-2.4
-3.8
0
0
0

income-statement-row.row.income-tax-expense

-2.58-3.3-2.4-0.9
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.net-income

-30.14-34.2-45.2-42.3
-30.3
-39.1
-21.4
-26.9
-21.2
-12
-7.2
-2.4
-3.8
0
0
0

Pogosto zastavljeno vprašanje

Kaj je OncoSec Medical Incorporated (ONCS) skupna sredstva?

OncoSec Medical Incorporated (ONCS) skupna sredstva so 21878368.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.000.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -4.923.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.000.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.000.

Kaj je OncoSec Medical Incorporated (ONCS) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -34179634.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 6174765.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 37012062.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 3683330.000.